SCHEMBL16626756

SCHEMBL16626756

COc1nc(OC(F)(F)F)ccc1Nc1ccc2c(CN(C)C(=O)OC(C)(C)C)cn(S(=O)(=O)c3cccnc3)c2c1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDE P14735 1/20 0.33
HTR6 P50406 5/20 0.33
FBP1 P09467 1/20 0.32
LMNA P02545 1/20 0.32
HTT P42858 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
PPARG P37231 1/20 0.31
PPARD Q03181 1/20 0.31
PPARA Q07869 1/20 0.31
RORC P51449 1/20 0.31
RIPK1 Q13546 1/20 0.31
CHRNB4 P30926 1/20 0.31
CHRNA3 P32297 1/20 0.31
BRAF P15056 1/20 0.31
ABCC9 O60706 1/20 0.31
ABCC8 Q09428 1/20 0.31
KCNJ11 Q14654 1/20 0.31
KCNJ8 Q15842 1/20 0.31
NAMPT P43490 2/20 0.30
TGFBR1 P36897 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16618610 0.92 HTR6 (0.36) IDEHTR6FBP1LMNAHTT
SCHEMBL17971587 0.91 HTR6 (0.34) IDEHTR6FBP1LMNARORC
SCHEMBL16626410 0.84 NAMPT (0.36) IDEHTR6FBP1HTTRORC
SCHEMBL16619162 0.80 LMNA (0.41) HTR6FBP1LMNAHTTSMN1; SMN2
SCHEMBL16626659 0.79 RORC (0.37) RORCHDAC1HDAC2HDAC6
SCHEMBL16618757 0.79 PDE4A (0.39) IDEHTR6HDAC1HDAC2HDAC6
SCHEMBL16626645 0.79 HTR6 (0.41) IDEHTR6HDAC1HDAC2HDAC6
SCHEMBL16626414 0.78 HTR6 (0.39) IDEHTR6HDAC1HDAC2HDAC6
SCHEMBL16626621 0.78 HTR6 (0.44) HTR6LMNAPPARGPPARDPPARA
SCHEMBL16626635 0.77 HTR6 (0.38) IDEHTR6HDAC1HDAC2HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP disclosed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
WO-2015050412-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME GIPR, PGC, SI IDE 2586/4885HTR6 166/4885FBP1 74/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.